Stocks Screener

Search any stock or ticker

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

How This Company Makes Money

Dividend Analysis ERF

Max Ratio

3.23

Dividend Yield

1.86 %

5Y Dividend Growth

74.00 %

Consecutive Years

5Y Average Payout Ratio

27.55 %

Dividend History ERF

1 year
3 years
5 years
10 years
15 years
11/21/2021 - 11/28/2021
Forward Annual Dividend Yield 1.86 %
Consecutive Years 0
Forward Annual Dividend 1.10 EUR
Consistent Years 0
Dividend CAGR 3Y -9.74 %
Continuous Dividends
Dividend CAGR 5Y 11.66 %
Payout Ratio TTM 28.72 %
Dividend CAGR 10Y 15.34 %
Ex Dividend Date 04/28/2025

The 5 Pillars Formula Checklist

The Five-Pillar Secret Formula Checklist is our simple, proven way to separate strong, lasting businesses from the rest. We look at five key pillars—sales growth, profit growth, Net Income, dividend safety, and debt levels. Together with Financial Score, they tell us if a company can keep growing, stay financially solid, and reliably pay dividends for decades.

Sales Growth ERF

Sales Growth – The Foundation of a Strong Business. Consistent revenue growth over the past 10-15 years is a key sign of a thriving company. It shows that demand for its products and services is increasing, allowing it to expand operations, gain market share, and invest in future growth.
1 year
3 years
5 years
10 years

Profit Growth / Profit Margin ERF

The Fuel for Company Growth. Revenue alone isn’t enough—what truly matters is how efficiently a company turns that revenue into consistent, growing profits. Profitability is the foundation of sustainable growth and long-term financial strength.
1 year
3 years
5 years
10 years

Net Income ERF

The True Measure of Financial Strength. Net income is what remains after all expenses, taxes, and costs. This is the company’s real earning power.
1 year
3 years
5 years
10 years

Payout Ratio TTM ERF

Dividend Payout Safety – Protecting Your Passive Income. A high dividend yield is meaningless if the company can’t afford to sustain it. We evaluate payout ratios to ensure the company is not overextending itself. The best companies have a balanced approach—paying generous dividends while still reinvesting in future growth. Dividend safety is crucial for long-term income stability.
1 year
3 years
5 years
10 years
15 years
11/21/2021 - 11/28/2021

Debt Ratio ERF

Debt Burden – Avoiding Financial Traps. Too much debt can cripple a company, even if its revenues and profits look great. We analyze how well a company manages its liabilities, ensuring that debt levels are under control.
1 year
3 years
5 years
10 years
11/21/2021 - 11/28/2021

Full Financial Performance

See how the company makes money over time—revenue, profits, dividends, and more. The charts on the right give you a quick view of growth trends so you can instantly spot consistency or red flags.

Eurofins Scientific SE ERF

1 year
3 years
5 years
10 years
Results 2019 Dynamics
* The data for this period has not yet been published

Bottom Line

Valuation Check

Shows if a stock is priced fairly by looking at peers and the company’s own history — a quick way to see if it’s a bargain or overpriced.

Value vs Peers

The company is measured against at least 10 rivals in the same sector. If it earns 25% more profit per share than the average, it’s Undervalued. If it earns 25% less, it’s Overvalued. In short: stronger earnings per share mean you’re getting a bargain, weaker ones mean you’re overpaying.

Value vs Itself ERF

P/E shows how many dollars investors pay in the stock price for each $1 of profit the company earns per share. Today’s P/E is compared with the company’s 10-year average. If the ratio is above that norm, you’re paying up for each dollar of profit. If it’s below, you’re getting more earnings for less.
1 year
3 years
5 years
10 years
11/21/2021 - 11/28/2021
Trailing PE 26.01
Forward PE 13.42
Enterprise Value Revenue 1.92
Price Sales TTM 1.46
Enterprise Value EBITDA 9.37
Price Book MRQ 2.23

Eurofins Scientific SE Dividends: 1.02 % Yield, History, Payment Schedule

ERF
Current price
59.04 EUR +0.44 EUR (+0.75%)
Last closed 58.58 EUR
ISIN FR0014000MR3
Sector Healthcare
Industry Diagnostics & Research
Exchange Euronext Paris
Capitalization 10 468 270 668 EUR
Yield for 12 month +26.67 %
1Y
3Y
5Y
10Y
15Y
ERF
11/21/2021 - 11/28/2021

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Advanced Highlights

Current Year

+6 965 516 141 EUR

Last Year

+6 528 204 783 EUR

Current Quarter

+1 809 771 565 EUR

Last Quarter

+3 539 676 688 EUR

Current Year

+4 722 040 736 EUR

Last Year

+621 695 614 EUR

Current Quarter

+405 945 991 EUR

Last Quarter

+352 434 474 EUR
EBITDA 1 433 988 497 EUR
Operating Margin TTM 13.16 %
Price to Earnings 26.01
Return On Assets TTM 5.46 %
PEG Ratio 0.71
Return On Equity TTM 8.68 %
Wall Street Target Price 55.32 EUR
Revenue TTM 7 159 219 851 EUR
Book Value 19.32 EUR
Revenue Per Share TTM
Dividend Share 0.60 EUR
Quarterly Revenue Growth YOY 5.70 %
Dividend Yield 1.86 %
Gross Profit TTM 1 616 969 766 EUR
Earnings per share 2.27 EUR
Diluted Eps TTM 2.27 EUR
Most Recent Quarter II 2025
Quarterly Earnings Growth YOY 16.00 %
Profit Margin 6.05 %

Technical Indicators ERF

For 52 Weeks

45.15 EUR 69.54 EUR
50 Day MA 60.67 EUR
Shares Short Prior Month
200 Day MA 58.81 EUR
Short Ratio
Shares Short
Short Percent